tiprankstipranks
Corbus Pharmaceuticals (GB:0SZI)
LSE:0SZI

Corbus Pharmaceuticals (0SZI) Financial Statements

0 Followers

Corbus Pharmaceuticals Financial Overview

Corbus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Corbus Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-1.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -9.27M$ -7.96M$ -18.62M$ -11.06M$ -8.18M
EBITDA$ -8.92M-$ -18.44M$ -10.59M$ -7.81M
Net Income Common Stockholders$ -10.04M$ -8.78M$ -17.69M$ -10.80M$ -8.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 28.73M$ 36.76M$ 44.42M$ 59.39M$ 66.23M
Total Assets$ 36.28M$ 43.72M$ 51.65M$ 66.31M$ 73.83M
Total Debt$ 22.86M$ 23.72M$ 24.84M$ 25.09M$ 25.52M
Net Debt$ -5.88M$ -13.04M$ -19.58M$ -34.30M$ -40.71M
Total Liabilities$ 35.97M$ 34.20M$ 35.19M$ 33.32M$ 31.88M
Stockholders Equity$ 311.02K$ 9.52M$ 16.46M$ 32.99M$ 41.95M
Cash Flow-
Free Cash Flow$ -7.18M-$ -15.11M$ -7.45M$ -7.25M
Operating Cash Flow$ -7.18M-$ -15.11M$ -7.45M$ -7.25M
Investing Cash Flow$ 10.90M-$ 5.55M$ 11.78M$ -5.97M
Financing Cash Flow$ -820.50K-$ -113.01K$ 234.32K$ -110.70K
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Corbus Pharmaceuticals Debt to Assets

Corbus Pharmaceuticals Cash Flow

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis